Pelvic Lymph Node Dissection Using Indocyanine Green Fluorescence Lymphangiography in Robotic Assisted Radical Prostatectomy for Non-Lymph Node or Distant Metastasis Prostate Cancer Patients
Yu-Feng Chuang(Tungs' Taichung MetroHarbor Hospital), Chin-Heng Lu(Tungs' Taichung MetroHarbor Hospital), Hung-Lin Chen(Biogen (United States)), Li‐Hua Huang(Zhujiang Hospital), Yen‐Chuan Ou(Tungs' Taichung MetroHarbor Hospital), Min‐Che Tung(National Chung Hsing University), Wei‐Chun Weng(Mackay Junior College of Medicine, Nursing and Management), Yi‐Sheng Lin(Peking University), Chao‐Yu Hsu(National Chung Hsing University), Yu‐Kang Chang(Tungs' Taichung MetroHarbor Hospital)
Cited by 0
Related Papers
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Oncology|2020|502
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
|European Urology|2006|176
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
|European Urology|2010|154
Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy
|British Journal of Urology|2010|141